SCIENTIFIC AND PHYSICAL COMMITTEE

Slides:

Advertisements

Similar presentations

Background information

Advertisements

Board Update: Strategic Planning, Continuing Education, and Opportunities to Get Involved Jean M. Moran Board member-at-large December 10, 2010.

African Aviation Training Organization

ICH Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria (RAAPAC) Overview and Update Robert H. King, Sr. Office of Pharmaceutical.

The Oviedo Convention from the Perspective of DG Research Dr. Lino PAULA European Commission DG Research, Governance and Ethics Unit.

Conference for FOOD PROTECTION Promoting Food Safety Through Collaboration.

Prof. A. De Wever SAFETY, EFFICACY, QUALITY AND RISK/BENFIT RATIO Source : Marc Czarka.

THE FIRST INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS Global Device Codes of Ethics/Conduct Roundtable Paris, France May 27, 2008 Philippe Laroche.

Introduction to Regulation

Introduction 3.03 Understand support services Introduction.

Regulation of Pharmaceuticals in Kenya

2 nd International ASIA QA FORUM EVENT INFO This event will be a venue for all QA specialists and scientists working in Asia to expand their intellectual.

Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.

On ICH Feb. 13, 2013 Toshi Tominaga Ph. D. Food and Drug Evaluation Center, Osaka City Univ. Hospital International Regulatory Harmonization Amid Globalization.

Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,

Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.

Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.

The Food, Drug, and Cosmetic Division Rick Perlman Chair

REVIEW OF THE RCA AGREEMENT 2013 RCARO Workshop on Strengthening the RCA/RCARO Activities and its Efficiency, 7-9 August 2013, Seoul, South Korea Alumanda.

3/3/2010Handshake to Success Crescent Healthcare is a premier infusion company founded in 1992 to provide home infusion services to patients with chronic.

*The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.

+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.

Audit Committee Roles & Responsibilities Audit Committee July 20, 2004.

ACCREDITED CONSULTANTS PVT LTD. (ACPL) WELCOMES YOU Your PHARMACOVIGILANCE PARTNER.

European Donation & Transplant Coordination Organisation The Donation & Procurement Section of ESOT and

EFPIA and IFPMA Code Compliance Strategies Richard BERGSTRÖM Chair, EFPIA Code Steering Committee Chair, IFPMA Code Compliance Network Presentation at.

Session 1.01 US Healthcare Professionals Abroad – Issues and Practical Solutions Caroline West – Senior VP, Chief Compliance and Risk Officer Shire Pharmaceuticals.

Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.

FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.

FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?

FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 22-23, 2008 Introduction and Update Helen N. Winkle Director, Office of.

1 QUALITY MANAGEMENT SYSTEM PRESENTATION TO BOTSWANA DRUG ADVISORY BOARD MEMBERS 13 th – 17 th AUGUST 2007.

FSMA Communications and Engagement for International Stakeholders March 21, 2016 Julie Moss, PhD, RD Deputy Director, International Affairs Staff, Center.

Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.

2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.

Establishment of Medical Device GMP Requirements Hsiau-Wen Huang, Ph. D. Senior Researcher Bureau of Pharmaceutical Affairs Department of Health.

NATIONAL QUALITY INFRASTRUCTURE (NQI) Engr. Cirila S. Botor VP-PhilMSTQ, Inc.

The IFPMA Code and how to set up a national self-regulation system Presentation to China/EU Pharmaceutical Industry Forum 17 May 2017, Shanghai, China.

Jim Bland Executive Director, CRIX International

Annual General Meeting (AGM)

HIMSS Standards Activities

African Aviation Training Organization

The south Florida chapter

Challenges and opportunities for professional acupuncturists in the UK

Center of Ethical Reinforcement for Human Research

3.03 Understand support services Introduction

ICH-GCP Avinash Kondawar M. Pharm Lead CRA

1st & 2nd General Membership Meeting & Technical Seminar

DIA Clinical Safety and Pharmacovigilance Community

UW Hospital and Clinics Organ Procurement Organization (OPO)

Lessons Learned: Past Present and Future Japan-USA Regulatory Interactions Erica Takai, PhD US Food and Drug Administration

Dr. Simone Borsci DEC London

American Intellectual Property Lawyers Association 2015 Spring Meeting Los Angeles, California April 29 – May 2, 2015 John Cabeca Director of the.

3.03 Understand support services Introduction

Jordan Food & Drug Administration

Hospital Mission The hospital Mission Statement defines the purpose of the hospital’s existence and provides guidance in its community service. All.

Beyond Academia.

3.03 Understand support services Introduction

Harmonization for Patient Centered Universal Health Coverage

Hak Yoel (Peter) YOU Republic of Korea

Distinguished Club Program

Introduction to TransCelerate

3.03 Understand support services Introduction

3.03 Understand support services Introduction

Patient Involvement in the Development and Safe Use of

3.03 Understand support services Introduction

Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.

A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.

Research transparency strategy

Approach: The Cuban Regulatory Strategy

Presentation transcript:

SCIENTIFIC AND PHYSICAL COMMITTEE 2016 ANNUAL Report Julie Anne S. Odarbe and Bella Buniel 28 Feb 2016

Members of the Committee Contents Introduction 1 Members of the Committee 2 2016 Accomplishments 3 2017 Plans and Programs 4

Julie Anne S. Odarbe PRO, Scientific and Physical Chair, Philippine Association of Medical Affairs Medical Device Regulatory Affairs Professionals Regulatory Affairs Leader, GE Philippines, Inc. ASEAN CoE Leader (Center for Excellence) AdProm and IRIS (Regulatory process) – GE Healthcare ASEAN 16 years in RA Experience (this includes Pharmacovigilance Reporting – local and abroad, Clinical Trial) 3 yrs in QA/QC Control 3yrs combined Product Management and Training Management, Logistics Handled drugs, biologics, food, cosmetics, devices

Bella Rozanna Buniel Board of Director, Co-chair, Scientific and Physical Chair, Philippine Association of Medical Affairs Medical Device Regulatory Affairs Professionals RA Manager and Drug Safety Officer, B Braun Medical Supplies, Inc. (BMSPH) Compliance Officer of BMSPH, B. Braun Avitum Phils., & Therapy Management Systems 9 yrs RA experience in Pharma/Cosmetics and Medical Device. 14 yrs in Manufacturing/Plant Management 8 yrs combined Retail Management, Logistics, GMP and R&D.

Members of the Committee Contents Introduction 1 Members of the Committee 2 2016 Accomplishments 3 2017 Plans and Programs 4

Scientific Committee The committee is responsible to provide structured device training program for both industry and stakeholders. It shall also partner with appropriate regulatory bodies and industry associations in carrying out capacity building programs that will benefit regulators and industry members.

Scientific and Physical Committee Chair: Juls Odarbe (GE Phils Inc) Co-chair: Bel Buniel (B Braun Medical) Members: 1. Reggie Patena (Medtronic) Clarice Humilde (Metropharma) Dexford Delas Llagas (J&J) Rona Dela Rosa (3M) Andrea Ero-Gonzales (Medtronic) Jona Manalili (New Marketlink) Vangie San Juan (B Braun Medical) Emegrace Milan (Boston Scientific) Che Alfonso (Marsman Drysdale)

Members of the Committee Contents Introduction 1 Members of the Committee 2 2016 Accomplishments 3 2017 Plans and Programs 4

KEY ACHIEVEMENT 2016 Technical Expertise Development Organized Special Meeting last April 5 2016 about E-LTO, PAIR submission and Code of Ethics in Bayanihan Hall, UNILAB. Organized 1st overnight GMM with Teambuilding in Club Balai last June 17 - 18 2016 11th (2nd) GMM 2016 and 5 yrs Anniversary last Dec 14, 2016 in Crowne Plaza Ortigas

1st GMM 2016 – Club Balai

11th GMM, 5th yr Anniversary and Christmas Party

AHWP 2016

Members of the Committee Contents Introduction 1 Members of the Committee 2 2016 Accomplishments 3 2017 Plans and Programs 4

GMMs 12th GMM 2017 – Feb 28 Topics: 1. Adoption of Code of Ethics 2. ISO 3. Business writing training 4. FDA updates 13th GMM 2017 – Nov/Dec 2017 1. Election 2. Christmas Party 3. FDA updates/NTC requirements

Special Training/ Workshop Topics: ( Special Training/ Workshop Topics: In-depth CSDT training (trainer from Regional colleague or Tony Low) – MDD/MD Classification (trainer from Regional colleague or Tony Low)

PRC Accreditation Application ( PRC Accreditation Application To start to apply for the PRC Accreditation for Accredited Trainer. To include CPE units per GMM or Special trainings

CSR ACTIVITY Benificiary: Orphanage: Hospicio Golden Acres Activities: ( CSR ACTIVITY Benificiary: Orphanage: Hospicio Golden Acres Activities: Gift giving Simple Christmas party Donations from members: Instead of having exchange gifts during Christmas party, members will donate money for the CSR (min Php 200.00)

Thank You !